Vitamin e
Berocca Pn, M.v.c. 9+, M.v.i, M.v.i. Lyophilized, Mvc, Vitaped (vitamin e) is an unknown pharmaceutical. Vitamin e was first approved as M.v.i.-12 lyophilized on 1985-08-08. It is used to treat alzheimer disease, drug-induced dyskinesia, hemolytic anemia, and vitamin e deficiency in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
737 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | 3 | 16 | 7 | 8 | 12 | 44 |
| Fatty liver | D005234 | EFO_0003934 | — | 1 | 7 | 5 | 8 | 9 | 30 |
| Syndrome | D013577 | — | — | 2 | 6 | 5 | 1 | 10 | 22 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 3 | 2 | 5 | 5 | 7 | 21 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | 2 | 3 | 6 | 7 | 19 |
| Oxidative stress | D018384 | EFO_1001905 | — | — | 3 | 1 | 1 | 12 | 17 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 2 | 3 | 2 | 1 | 9 | 16 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 3 | 2 | 2 | 3 | 6 | 15 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 2 | 4 | 2 | 4 | 4 | 15 |
| Male infertility | D007248 | EFO_0004248 | N46 | 1 | 2 | — | 2 | 9 | 14 |
Show 99 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 7 | 3 | 1 | — | 13 | 24 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 5 | 5 | — | 8 | 16 |
| Inflammation | D007249 | MP_0001845 | — | — | 3 | 1 | — | 13 | 16 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 6 | 1 | — | 5 | 13 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | 4 | 3 | — | 6 | 12 |
| Mitochondrial diseases | D028361 | EFO_0000591 | — | 1 | 7 | 3 | — | 3 | 12 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | 3 | 4 | — | 2 | 10 |
| Colorectal neoplasms | D015179 | — | — | 1 | 3 | 2 | — | 3 | 9 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | 2 | 1 | — | 6 | 9 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | 1 | 5 | — | 2 | 9 |
Show 146 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Asthma | D001249 | EFO_0000270 | J45 | 3 | 3 | — | — | 2 | 8 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 3 | — | — | 3 | 6 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 3 | 1 | — | — | 1 | 5 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 3 | — | — | — | 3 |
| Non-small-cell lung carcinoma | D002289 | — | — | — | 3 | — | — | — | 3 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | 1 | — | — | 2 | 3 |
| Autism spectrum disorder | D000067877 | — | F84.0 | — | 1 | — | — | 2 | 3 |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | — | 1 | — | — | 2 | 3 |
| Dementia | D003704 | EFO_0003862 | F03 | 1 | 1 | — | — | 1 | 3 |
| Acne vulgaris | D000152 | EFO_0003894 | L70 | — | 1 | — | — | 2 | 3 |
Show 88 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Macular edema | D008269 | — | — | 3 | — | — | — | 1 | 4 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 1 | — | — | — | 3 | 4 |
| Heart failure | D006333 | EFO_0003144 | I50 | 3 | — | — | — | — | 3 |
| Allergic rhinitis | D065631 | — | J30.9 | 2 | — | — | — | 1 | 3 |
| Rhinitis | D012220 | EFO_0008521 | J31 | 1 | — | — | — | 2 | 3 |
| Female infertility | D007247 | EFO_0008560 | N97 | 1 | — | — | — | 2 | 3 |
| Fatigue | D005221 | — | R53.83 | 1 | — | — | — | 2 | 3 |
| Edema | D004487 | — | R60.9 | 3 | — | — | — | — | 3 |
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | 1 | 2 |
| Sleep apnea syndromes | D012891 | EFO_0003877 | G47.3 | 1 | — | — | — | 1 | 2 |
Show 24 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 9 | 9 |
| Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 7 | 7 |
| Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | — | — | 6 | 6 |
| Motor activity | D009043 | EFO_0003940 | — | — | — | — | — | 5 | 5 |
| Alopecia | D000505 | — | L64 | — | — | — | — | 5 | 5 |
| Micronutrients | D018977 | — | — | — | — | — | — | 5 | 5 |
| Skin aging | D015595 | EFO_0005422 | — | — | — | — | — | 5 | 5 |
| Alopecia areata | D000506 | EFO_0004192 | L63 | — | — | — | — | 4 | 4 |
| Hypotrichosis | D007039 | — | — | — | — | — | — | 4 | 4 |
| Keratoconjunctivitis sicca | D007638 | EFO_1000906 | — | — | — | — | — | 4 | 4 |
Show 152 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Vitamin e |
| INN | phytomenadione |
| Description | (R,R,R)-alpha-tocopherol is an alpha-tocopherol that has R,R,R configuration. The naturally occurring stereoisomer of alpha-tocopherol, it is found particularly in sunflower and olive oils. It has a role as an antioxidant, a nutraceutical, an antiatherogenic agent, an EC 2.7.11.13 (protein kinase C) inhibitor, an anticoagulant, an immunomodulator, an antiviral agent, a micronutrient, an algal metabolite and a plant metabolite. It is an enantiomer of a (S,S,S)-alpha-tocopherol. |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 10191-41-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3989727 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | A034SE7857 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,645 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use